Participant outcomes and preferences in Alzheimer's disease clinical trials: The electronic Person-Specific Outcome Measure (ePSOM) development program

INTRODUCTION: Current pharmacological interventions for Alzheimer's dementia delay symptom progression for about a year. Although the outcomes in earlier disease states may include changes in biomarkers, the clinical effectiveness of any intervention can ultimately only be assessed by a patient...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Alzheimers Dement (N Y)
Main Authors: Saunders, Stina, Muniz-Terrera, Graciela, Watson, Julie, Clarke, Charlotte L., Luz, Saturnino, Evans, Alison R., Ritchie, Craig W.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2018
Teme:
Perspective
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6296160/
https://ncbi.nlm.nih.gov/pubmed/30581975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2018.10.013
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki